Waddell & Associates’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-653
Closed -$309K 563
2026
Q1
$309K Sell
653
-114
-15% -$57.4K 0.02% 333
2025
Q4
$358K Buy
+767
New +$356K 0.02% 237

Other funds holding HCA

Waddell & Associates's HCA Position: Q2 2026 in Review

Waddell & Associates sold out of HCA Healthcare (HCA) in Q2 2026, closing a stake of 653 shares — an estimated $309K sold.

Waddell & Associates first reported a position in HCA in Q4 2025 and held it in 2 quarters. The position peaked at $358K in Q4 2025. 407 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Waddell & Associates reported no remaining HCA Healthcare position as of Q2 2026 after selling out during the quarter.
  • Waddell & Associates sold 653 HCA Healthcare shares in Q2 2026, an estimated $309K.
  • Waddell & Associates first reported a position in HCA Healthcare in Q4 2025 and held it in 2 quarters.
  • Waddell & Associates's HCA Healthcare position peaked at $358K in Q4 2025.
  • 407 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Waddell & Associates's 13F filing for Q2 2026, filed 15 Jul 2026.